1. Home
  2. Analysis
  3. Capecitabine
  4. Dexamethasone-acetate

Capecitabine and Dexamethasone acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 9 people who take Capecitabine and Dexamethasone acetate. Common interactions include pulmonary embolism among females, and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Capecitabine and Dexamethasone acetate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

9 people who take Capecitabine and Dexamethasone acetate together, and have interactions are studied.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. Currently, eHealthMe is studying from 55,211 Capecitabine users.

What is Dexamethasone acetate?

Dexamethasone acetate has active ingredients of dexamethasone acetate. Currently, eHealthMe is studying from 1,662 Dexamethasone acetate users.

Number of Capecitabine and Dexamethasone acetate reports submitted per year:

Capecitabine and Dexamethasone acetate drug interactions.

Common Capecitabine and Dexamethasone Acetate drug interactions by gender *:

female:

  1. Pulmonary embolism
  2. Acantholysis
  3. Anhedonia
  4. Anxiety
  5. Aphthous stomatitis
  6. Arthralgia
  7. Ascites
  8. Back pain
  9. Bone pain
  10. Cellulitis

male:

  1. Diarrhoea
  2. Embolism venous

Common Capecitabine and Dexamethasone Acetate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Foetal exposure during pregnancy
  2. Foetal growth restriction

40-49:

n/a

50-59:

  1. Acantholysis
  2. Anhedonia
  3. Anxiety
  4. Aphthous stomatitis
  5. Arthralgia
  6. Ascites
  7. Back pain
  8. Bone pain
  9. Cellulitis
  10. Central nervous system inflammation

60+:

  1. Deep vein thrombosis
  2. Disease progression
  3. Embolism venous
  4. Fatigue
  5. Hepatic enzyme increased
  6. Nausea
  7. Oedema peripheral
  8. Palpitations
  9. Pulmonary embolism
  10. Swelling

* Approximation only. Some reports may have incomplete information.

Do you take Capecitabine and Dexamethasone acetate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Capecitabine drug interactions:

Browse interactions between Capecitabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dexamethasone acetate drug interactions:

Browse interactions between Dexamethasone acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on capecitabine and dexamethasone acetate (the active ingredients of Capecitabine and Dexamethasone acetate, respectively), and Capecitabine and Dexamethasone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Capecitabine and Dexamethasone acetate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.